Literature DB >> 3518332

Morphometric comparison of endolymphatic and perilymphatic spaces in human temporal bones.

M Igarashi, K Ohashi, M Ishii.   

Abstract

To measure the endolymphatic and perilymphatic spaces, we used human temporal bones (horizontal serial sections) under two selection criteria: absence of otological pathology, and absence of artifact in the membranous labyrinth (boundary between endolymphatic and perilymphatic spaces) maintaining an intact structural integrity. Under magnified projection, the area of scala tympani, scala vestibuli, scala media, vestibular endolymphatic space, and vestibular perilymphatic space were measured separately, using a microcomputer digitizing tablet. Three repeated measurements were obtained and averaged. The mean total labyrinthine fluid space was 204.5 mm3; the mean total endolymphatic space was 38.1 mm3 and mean total perilymphatic space 166.4 mm3. The mean total vestibular fluid space was 120.9 mm3 and mean total cochlear fluid space 83.6 mm3. In the vestibule, the perilymphatic space occupied 74.8%, and the endolymphatic space, 25.2%, whereas 90.8% of the cochlear fluid space was occupied by perilymph.

Entities:  

Mesh:

Year:  1986        PMID: 3518332     DOI: 10.3109/00016488609132823

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  14 in total

1.  In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants.

Authors:  Ya Liu; Claude Jolly; Susanne Braun; Thomas Stark; Elias Scherer; Stefan K Plontke; Jan Kiefer
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-29       Impact factor: 2.503

2.  The role of 3-canal biomechanics in angular motion transduction by the human vestibular labyrinth.

Authors:  Marytheresa A Ifediba; Suhrud M Rajguru; Timothy E Hullar; Richard D Rabbitt
Journal:  Ann Biomed Eng       Date:  2007-03-22       Impact factor: 3.934

3.  Predictions of middle-ear and passive cochlear mechanics using a finite element model of the pediatric ear.

Authors:  Xuelin Wang; Douglas H Keefe; Rong Z Gan
Journal:  J Acoust Soc Am       Date:  2016-04       Impact factor: 1.840

Review 4.  Innovative pharmaceutical approaches for the management of inner ear disorders.

Authors:  Umberto M Musazzi; Silvia Franzé; Francesco Cilurzo
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

Review 5.  Microsystems technologies for drug delivery to the inner ear.

Authors:  Erin E Leary Pararas; David A Borkholder; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2012-02-21       Impact factor: 15.470

6.  A nanoliter resolution implantable micropump for murine inner ear drug delivery.

Authors:  Farzad Forouzandeh; Xiaoxia Zhu; Ahmed Alfadhel; Bo Ding; Joseph P Walton; Denis Cormier; Robert D Frisina; David A Borkholder
Journal:  J Control Release       Date:  2019-01-25       Impact factor: 9.776

7.  Intracochlear Drug Delivery Through the Oval Window in Fresh Cadaveric Human Temporal Bones.

Authors:  Woo Seok Kang; Kim Nguyen; Charles E McKenna; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2016-03       Impact factor: 2.311

8.  Microfabricated reciprocating micropump for intracochlear drug delivery with integrated drug/fluid storage and electronically controlled dosing.

Authors:  Vishal Tandon; Woo Seok Kang; Tremaan A Robbins; Abigail J Spencer; Ernest S Kim; Michael J McKenna; Sharon G Kujawa; Jason Fiering; Erin E L Pararas; Mark J Mescher; William F Sewell; Jeffrey T Borenstein
Journal:  Lab Chip       Date:  2016-03-07       Impact factor: 6.799

Review 9.  Inner ear drug delivery for auditory applications.

Authors:  Erin E Leary Swan; Mark J Mescher; William F Sewell; Sarah L Tao; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2008-09-21       Impact factor: 15.470

10.  A dual wedge microneedle for sampling of perilymph solution via round window membrane.

Authors:  Hirobumi Watanabe; Luis Cardoso; Anil K Lalwani; Jeffrey W Kysar
Journal:  Biomed Microdevices       Date:  2016-04       Impact factor: 2.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.